Isla Campbell
Adisyn Eyes Semiconductor Interconnect Solutions after Low-Temp Graphene Breakthrough
Adisyn achieves low-temp graphene via ALD, enabling continuous 1cm x 1cm film under 450°C, a potential leap for copper interconnects.
PPK Group to Sell CIB Stake for Up to A$33.43m in Strategic Divestment
PPK Group to sell 39.85% CIB stake to Mehler Vario for up to A$33.43m (A$27.45m upfront, up to A$5.98m earn-out) in strategic divestment.
SRJ Technologies Lands US$4.4m Three-Year UAE Robotic Inspection Contract
SRJ Technologies wins US$4.4m UAE three-year robotic leak-detection contract, boosting Middle East expansion and potential renewal.
Kinetiko Energy Unveils Rolling Cluster Strategy Targeting 2027 for First Gas Revenue
Kinetiko Energy launches Rolling Cluster Development Strategy targeting first gas revenue in Q2/Q3 2027 from 6.0 Tcf via staged CNG-LNG rollout.
Matrix Composites Engineering to be Acquired by AIH under Binding Scheme
Matrix Composites to be acquired by AIH for A$0.40 cash; 66.7% premium; binding scheme, unanimous board support; FIRB and court approvals; expected July 2026.
Buru Energy Secures $5.3M Placement to Fund Rafael Gas Project with Enhanced Economics
Buru Energy raises A$5.3M via two-tranche placement to fund Rafael gas project; says optimisations lift pre-tax cash flow 20-47% and IRR to 42-80%.
Global Momentum Continues as Immuron Delivers Double-Digit Q3 Sales Growth in Australia
Immuron delivers double-digit Q3 Travelan growth, led by Australia +15% to AUD 0.9m; Canada doubles; global Q3 sales AUD 1.5m +16%.
NZ King Salmon Hikes FY26 Guidance on Strong Summer Farming
NZ King Salmon lifts FY26 guidance on strong summer farming; expects NZ$19–27m earnings, pro-forma EBIT NZ$10–18m, harvest up to 6,100t.
Eden Innovations Launches EdenShield Division in Defence and Infrastructure Push
Eden Innovations launches EdenShield, defence-focused CNT concrete additives; $4.05m placement funds rapid expansion and dual-fuel backup power push.
West Coast Silver Identifies New Priority Drill Target at Elizabeth Hill Following DHEM Results
West Coast Silver discovers drill-ready DHEM conductor at Elizabeth Hill, aligning with historic high-grade silver; immediate drill test underway.
Lightning Minerals Pivots to Gold-Led Strategy with Mt Turner Project
Lightning Minerals pivots to gold with Mt Turner as flagship; 20.4m @ 2.4 g/t Au incl 1.9m @ 10.5 g/t Au; May 2026 drilling; divests lithium to unlock value.
BlinkLab Raises A$17.5m to Fund FDA Autism Diagnostic Clearance and Advance ADHD Trials
BlinkLab raises oversubscribed A$17.5m to push FDA autism Dx1 clearance and start ADHD Dx2 trials; Morocco rollout underpins real-world data.
DGL Group to Progress Strategic Projects After Posting Lower H1 FY26 Earnings
DGL Group H1: revenue down 5.8% to $225.2m; NPAT loss, yet advancing NSW waste plant, Unanderra recycling and ERP as ASX trading resumes.
Taiton Resources Raises $1.25m as Yogi Drilling Commences
Taiton Resources begins Yogi IOCG drilling as it raises $1.25m to fund Highway Project exploration; assay results expected in June.
Bass Oil Mobilises Drilling Rig for Bunian 6 Well, Targeting 750 bopd Production
Bass Oil mobilises rig for Bunian 6 in Indonesia, targeting 750 bopd total; Bass share ~410 bopd as May–June 2026 production starts.
Hiremii Validates AI Talent Platform with First Paying SaaS Customers
Hiremii lands its first two paying SaaS customers for AI talent platform, validating market readiness as funding fuels growth.
Genetic Signatures Inks 10-Year Danish Supply Deal for GI Screening Technology
GSS signs 10-year Danish deal with Hvidovre Hospital for EasyScreen Pan-Enteric; boosts recurring revenue, EMEA growth; first-year 28k samples from Sept 2026.
OD6 Metals Reports Ultra-High-Grade Fluorspar Intercepts at Horseshoe Prospect
OD6 Metals hits ultra-high-grade fluorspar at Horseshoe (Quinn NV): 12m @ 68.9% CaF2 (peak 79.7%), open-ended; expands DSO/MetSpar case, Fast 41 potential.
Orthocell Secures Access to 221 US Military & VA Medical Centres for Remplir
Orthocell wins access to 221 US DoD/VA centres for Remplir, a major US market expansion as HY26 revenue hits A$6.2m and cash sits at A$49.4m.
Immutep Granted FDA Orphan Drug Designation for Efti in Soft Tissue Sarcoma
Immutep wins FDA Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma, boosting exclusivity and regulatory support as TACTI-004 winds down.